11-114705808-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_182495.6(NXPE2):āc.956A>Gā(p.Gln319Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000967 in 1,509,104 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_182495.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NXPE2 | NM_182495.6 | c.956A>G | p.Gln319Arg | missense_variant | 5/6 | ENST00000389586.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NXPE2 | ENST00000389586.6 | c.956A>G | p.Gln319Arg | missense_variant | 5/6 | 5 | NM_182495.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152198Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000491 AC: 6AN: 122158Hom.: 0 AF XY: 0.0000460 AC XY: 3AN XY: 65184
GnomAD4 exome AF: 0.0000995 AC: 135AN: 1356788Hom.: 0 Cov.: 29 AF XY: 0.000127 AC XY: 85AN XY: 668432
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152316Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.956A>G (p.Q319R) alteration is located in exon 5 (coding exon 5) of the NXPE2 gene. This alteration results from a A to G substitution at nucleotide position 956, causing the glutamine (Q) at amino acid position 319 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at